机构地区:[1]Center for Cell Lineage and Development,Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine,Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China [2]Child Development and Behavior Center,The Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China [3]University of Chinese Academy of Sciences,Beijing 100049,China [4]Centre for Regenerative Medicine and Health,Hong Kong Institute of Science&Innovation,Chinese Academy of Sciences,Hong Kong 999077,China [5]Center for Cell Lineage and Atlas(CCLA),Bioland Laboratory,Guangzhou 510005,China [6]Joint School of Life Sciences,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China [7]Guangzhou Medical University,Guangzhou 511436,China [8]The Fifth Affiliated Hospital of Guangzhou Medical University,Guangzhou 510700,China [9]Guangzhou Laboratory,Guangzhou 510005,China [10]Animal Research Center,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China
出 处:《Science Bulletin》2024年第22期3533-3546,共14页科学通报(英文版)
基 金:supported by National Science Foundation of China(32225012);National Key R&D Program of China(2019YFA0110200);Health@Inno HK Program launched by Innovation Technology Commission of the Hong Kong SAR,China,Youth Innovation Promotion Association,Chinese Academy of Sciences(Jie Wang),National Science Foundation of China(32000414,32000503,and 32000501);The Science and Technology Program of Guangzhou 201804020052 and 202102021039;the Pearl River Talent Recruitment Program(2021ZT09Y233);Basic Research Project of Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,(GIBHBRP23-01,GIBHBRP23-02);Frontier Science Research Program of the CAS ZDBS-LY-SM007;Science and Technology Planning Project of Guangdong Province,China(2023B1212060050 and 2023B1212120009)。
摘 要:KMT2D,a H3K4me1 methyltransferase primarily regulating enhancers,is a leading cause of KABUKI syndrome.This multisystem disorder leads to craniofacial and cognitive abnormalities,possibly through neural crest and neuronal lineages.However,the impacted cell-of-origin and molecular mechanism of KMT2D during the development of KABUKI disease remains unknown.Here we have optimized a brain organoid model to investigate neural crest and neuronal differentiation.To pinpoint KMT2D's enhancer target,we developed a genome-wide cis-regulatory element explorer(GREE)based on single-cell multiomic integration.Single cell RNA-seq revealed that KMT2D-knockout(KO)and patient-derived organoids exhibited neural crest deformities and GABAergic overproduction.Mechanistically,GREE identified that KMT2D targets a roof-plate-like niche cell and activates the niche cell-specific WNT3A enhancer,providing the microenvironment for neural crest and neuronal development.Interestingly,KMT2D-mutated mice displayed decreased WNT3A expression in the diencephalon roof plate,indicating impaired niche cell function.Deleting the WNT3A enhancer in the organoids presented phenotypic similarities to KMT2D-depletion,emphasizing the WNT3A enhancer as the predominant target of KMT2D.Conversely,reactivating WNT signaling in KMT2D-KO rescued the lineage defects by restoring the microenvironment.Overall,our discovery of KMT2D's primary target provides insights for reconciling complex phenotypes of KABUKI syndrome and establishes a new paradigm for dissecting the mechanisms of genetic disorders from genotype to phenotype.
关 键 词:KMT2D ENHANCER NICHE Cerebral organoids Single-cell multiome
分 类 号:R741[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...